EU Puts Spotlight On $21B J&J-Synthes Merger
Europe's chief regulator will investigate the potentially anti-competitive implications of the $21.3 billion merger between pharmaceuticals giant Johnson & Johnson and medical device maker Synthes Inc., the agency announced Friday....To view the full article, register now.
Already a subscriber? Click here to view full article